Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Aortic aneurysms

Aortic aneurysms are permanent dilatations of the aorta in which increased caliber reflects changes in the structure and load-bearing capacity of the wall. The traditional definition of an arterial aneurysm uses a diameter at least one and a half times that expected for the segment concerned; in the aorta, however, this rule must be adapted to location and clinical context. The aortic root and ascending aorta require different interpretation from the abdominal aorta, because the likelihood of complications may become significant before a 50% increase over the expected value has been reached.

The term describes an anatomical configuration, not a single cause. An aneurysm may arise from hereditary predisposition, accompany a bicuspid aortic valve, result from degenerative remodeling or be caused by inflammation, infection or a previous dissection. Recognizing the cause changes the meaning of a given measurement: two aortas with the same diameter may have markedly different rates of progression, susceptibility to rupture and treatment indications. A complete diagnosis must therefore include location, extent, morphology, likely etiology and any signs of instability.

The frequency of sporadic aneurysms increases with age, but inherited thoracic aneurysms can also occur in young adults. Abdominal aneurysms predominantly affect older men and are strongly associated with smoking; they are less common in women, but seemingly comparable size does not necessarily imply equivalent risk. Epidemiological estimates depend on screening uptake and the definition used: a surgical case series, an ultrasound-screened population and a hospital diagnosis registry capture different stages of disease and are not directly comparable.

Clinical importance stems from an often prolonged silent phase and the possibility of sudden events. Absence of pain does not demonstrate stability, while finding a dilatation alone does not mean immediate intervention is beneficial. Management lies between these extremes: identifying individuals for whom surveillance is appropriate and recognizing when cumulative disease risk exceeds repair risk. This assessment requires measurements comparable over time and an outlook that includes life expectancy, comorbidities and individual preferences.

Anatomical locations and main aneurysm types

A thoracic aortic aneurysm may involve the root, ascending aorta, arch or descending aorta above the diaphragm. These segments differ in development, wall structure, relationships to organs and treatment options. Proximal dilatation may interfere with the valve and coronary origins; arch dilatation involves a region essential for cerebral perfusion; the descending aorta gives rise to branches contributing to spinal cord circulation. Location is therefore part of the functional diagnosis, as well as a topographical description.

In an aortic root aneurysm, enlargement of the sinuses and supporting structures may impair valve leaflet coaptation even when there is no primary leaflet lesion. An ascending aortic aneurysm instead affects the tubular segment and may spare the root or coexist with root dilatation. Distinguishing these phenotypes helps establish the origin of any regurgitation and plan reconstruction correctly. Replacement of the tubular aorta alone and replacement of the root are procedures with different anatomical objectives.

An aortic arch aneurysm may extend to the supra-aortic branches or lie between adjacent segments that are already diseased. Its complexity stems from the need to protect the brain and maintain branch continuity during repair. In a descending thoracic aortic aneurysm, assessment must also consider lesion length, the quality of landing zones for any stent graft and blood supply to the spinal cord. Merely labeling both lesions thoracic is therefore insufficient to assign them the same treatment pathway.

When dilatation crosses the diaphragm and also affects the abdominal aorta, it is called a thoracoabdominal aneurysm. Involvement of visceral and renal arteries calls for strategies to reconstruct or preserve their perfusion. An abdominal aortic aneurysm is frequently infrarenal but may approach, involve or extend above the renal arteries. The relationship to these branches distinguishes a relatively standardized repair from a complex procedure; maximum size alone does not describe the difference or establish suitability for endovascular treatment.

Morphology may be fusiform, with dilatation extending around the circumference, or saccular, with a localized bulge. A saccular lesion warrants particular attention to infection, penetrating ulcer and traumatic injury, but does not automatically identify any of these causes. In a true aneurysm, the wall, although altered, bounds the dilatation; in a pseudoaneurysm, there is loss of wall continuity contained by surrounding tissues or scar structures. The latter condition must not be assessed by mechanically applying size thresholds developed for degenerative fusiform aneurysms, because the containment mechanism differs.

Etiology and factors favoring development

The most useful etiological distinction separates processes that directly impair the wall from conditions that increase loading or hinder repair. In hereditary forms, abnormalities of structural proteins, cellular signaling or the contractile apparatus may render the aorta vulnerable for many years before obvious dilatation. A family history of dissection, thoracic aneurysm or premature sudden death therefore has a different significance from simply having common cardiovascular risk factors. Lack of skeletal, skin or ocular manifestations does not rule out a genetically determined disease.

Marfan and Loeys–Dietz syndromes are recognizable examples of systemic predisposition, but many families have disease predominantly confined to the aorta. The genetic defect may affect initial location, dissection risk at relatively small diameters and the need to assess other arterial territories. A bicuspid aortic valve is another important setting: associated dilatation results from interactions between tissue characteristics, cardiovascular development and flow distribution. Severity of valvular stenosis alone does not explain the degree of aortopathy.

In sporadic forms,hypertension increases pulsatile wall stress, while aging is accompanied by changes in elastin and cellular adaptive capacity. Smoking plays a particularly strong role in both the development and progression of abdominal aneurysm. Atherosclerosis is often associated with abdominal and descending aortic lesions but is not a universal explanation for aortic dilatation. An aneurysmal root in a young person without plaques and infrarenal dilatation in an older smoker must not be interpreted as different stages of the same disease.

The inflammation may damage elastic components and promote dilatation even long after initial systemic activity. Large-vessel vasculitis and IgG4-related disease may produce different presentations, sometimes with wall thickening, periaortic fibrosis or associated stenosis. With infection, tissue destruction may instead be rapid and accompanied by an irregular sac, pain and systemic signs. The traditional term mycotic is used for infected aneurysms, including those of bacterial origin, and must not lead to an exclusive search for fungi.

An aneurysm may also arise during remodeling of a chronic dissection, when persistent flow and pressure in the false lumen sustain expansion of the entire vessel. Trauma, endovascular procedures and surgical anastomoses may instead favor pseudoaneurysms through distinct mechanisms. A history of prior surgery therefore does not eliminate the need to characterize any new dilatation. Knowing whether it involves degenerated native aorta, a dissected wall or anastomotic dehiscence changes both required investigations and urgency.

Pathogenesis and pathophysiological consequences

The aortic wall withstands millions of expansion cycles through cooperation among elastic lamellae, collagen, smooth muscle cells and extracellular matrix. Elastin provides distensibility at physiological pressures, whereas progressively recruited collagen limits excessive stretching. Cells sense forces through matrix–cytoskeleton connections and regulate synthesis, organization and removal of structural components. An aneurysm develops when this remodeling balance can no longer maintain geometry and strength adequate for hemodynamic load.

In thoracic forms, smooth muscle cell loss, elastic fiber fragmentation and accumulation of proteoglycan-rich material in the media may be important. Inherited defects of fibrillin, actin, myosin or signaling pathways disrupt different parts of the system and do not necessarily cause identical clinical findings. Increased molecular signaling in tissue does not establish that pharmacologically blocking it will improve outcomes. Translating a pathogenic discovery into treatment requires clinical trials, especially when the same biological pathway has both reparative and harmful functions.

In abdominal aneurysms, inflammatory infiltration, proteolytic activity and matrix loss contribute to a cycle of injury and ineffective repair. The mural thrombus, often present in larger dilatations, changes local diffusion conditions and may contain biologically active cells and mediators. It does not guarantee protection against rupture and its mere presence does not justify anticoagulation. An apparently narrower perfused lumen also does not mean that the sac's external diameter or risk has decreased.

Expansion increases the load that the remaining wall must bear, but the relationship is not fully described by a geometric formula. Curvature, thickness, tissue composition and stress distribution vary from point to point. Rupture occurs when local strength is exceeded, whereas dissection entails separation of wall layers by blood. The two events may coexist but are not synonymous and do not always require marked pre-existing dilatation. Diameter remains an essential practical risk indicator without becoming a direct measure of fragility.

Hemodynamic and mechanical consequences depend on location. Root deformation may cause aortic regurgitation and left ventricular volume overload; a large thoracic sac may compress the airways, esophagus or nerves; thrombotic material may embolize into distal branches. Aortic stiffness may also increase ventricular load independently of aneurysm size. These mechanisms explain why complete assessment must include cardiac function, anatomical relationships and organ perfusion rather than focusing solely on the maximum diameter.

Clinical manifestations, history and physical examination

Most stable aneurysms are detected without symptoms during ultrasound, echocardiography or tomographic imaging performed for other reasons. When pain occurs, it is necessary to establish whether it can plausibly be attributed to the lesion and whether its features are new. Persistent chest, back, lower back or abdominal pain may accompany expansion or compression; sudden severe onset, particularly with syncope, hypotension or neurological deficits, requires consideration of an acute complication. A previously reassuring examination does not exclude a change since that time.

Chronic symptoms may suggest the involved segment without identifying it with certainty. Dyspnea and reduced exercise capacity suggest possible valve disease or ventricular dysfunction; dysphagia, hoarseness and cough may result from altered mediastinal relationships. An abdominal pulsation or mass may be felt, but many dilatations are not noticeable. A painful, cyanotic toe or a peripheral ischemic event may result from embolization. Fever, weight loss and malaise instead warrant evaluation for an infectious or inflammatory process.

The medical history includes tobacco exposure, blood pressure control, valvular disease, trauma, infections, vasculitis and prior interventions. Previous imaging documentation is more informative than recalling the diameter alone: segment, plane and measurement conventions may differ. Family history addresses aneurysms, dissections, aortic interventions and sudden deaths, specifying ages and circumstances. Pregnancy intentions are relevant in people of reproductive potential, because increased cardiovascular loading may change the management of an existing predisposition.

The physical examination primarily assesses hemodynamic stability, perfusion, pulses and possible blood pressure differences between limbs. Auscultation may identify an aortic murmur and signs of congestion; abdominal palpation may detect an expansile mass, with sensitivity limited by body habitus and lesion size. Manifestations of connective tissue disease, inflammatory signs and neurological deficits are also sought. A normal examination is compatible with a major aneurysm and does not replace imaging; likewise, absence of the classic triad of pain, pulsatile mass and shock does not exclude abdominal rupture.

Investigations, diagnosis and determination of extent

Diagnosis is based on anatomical imaging; there is no blood test that can ordinarily confirm or rule out a stable aneurysm. A maximum diameter of at least 30 mm is commonly used as the operational definition for the abdominal aorta, specifying the method and measurement boundaries. For the root and ascending aorta, assessment takes age, sex and body size into account: descriptive thresholds for dilatation and aneurysm do not coincide with surgical indications. Increased caliber should be confirmed on technically adequate imaging before it becomes a diagnosis with permanent consequences.

Abdominal ultrasound is suitable for screening and surveillance of many infrarenal aneurysms because it can be repeated and does not use radiation. Transthoracic echocardiography provides information on the root, proximal ascending aorta, valve and left ventricle. The limitations differ: bowel gas and obesity may impair abdominal ultrasonography, whereas some thoracic segments remain difficult to visualize externally. A good image of one segment does not justify declaring the entire aorta normal, particularly when inherited disease is suspected or a lesion is extensive.

CT angiography defines diameter, length, branches, calcifications, thrombus and signs of complications and is central to repair planning. MRI can provide anatomical and functional assessment without radiation exposure and is especially useful for selected repeated follow-up studies. Choice depends on urgency, renal function, implanted devices, tolerance and local availability. In suspected rupture or dissection, evaluation must be rapid and appropriate to patient stability; scheduled surveillance imaging is not an adequate alternative to emergency assessment.

Measurements should be obtained perpendicular to the vessel axis, avoiding an oblique section that turns tortuosity into false dilatation. Reports should state whether inner or outer edges are used, at what cardiac phase and at which level. Thrombus must not be excluded from the external measurement of a sac when that is the measurement required by the protocol. A difference of a few millimeters between reports may be technical: direct comparison of images, preferably using the same method, should precede attributing the change to biological growth.

After detection, extent and context are established. Imaging looks for other dilatations, associated dissection, ulcers, relationships to visceral or supra-aortic branches, and signs of periaortic inflammation. Echocardiography completes valve and ventricular function assessment. In suggestive phenotypes, genetic counseling and family screening are undertaken; with fever or suspicious morphology, blood cultures and targeted investigations are ordered. Etiological investigation should address a plausible suspicion, because indiscriminate panels may produce incidental results that are difficult to interpret without improving care.

The screening has different aims in the two major regions. For abdominal aneurysm, programs target population groups defined by age, sex and risk, with smoking history especially relevant. For inherited thoracic forms, identifying relatives at risk is a central strategy, even when the index case has no identifiable genetic variant. A negative genetic test does not mean a normal aorta, and a variant of uncertain significance is insufficient to establish that a relative has disease or requires surgery.

Treatment, surveillance and choice of repair

Conservative treatment includes blood pressure control, smoking cessation and management of comorbidities. Drug choice depends on etiology and coexisting indications: beta-blockers and angiotensin receptor blockers have a specific role in some thoracic aortopathies, whereas statins are mainly used for atherosclerotic risk. No universal drug treatment has been shown to make an aortic aneurysm regress. Even biologically plausible interventions require clinical verification: doxycycline, for example, did not slow the growth of small abdominal aneurysms in the relevant randomized trial.

The surveillance is structured treatment, not passive waiting. It specifies the examination, interval, blood pressure targets and what to do if symptoms occur. Intervals shorten near an intervention threshold, when growth is confirmed or when the cause raises risk. They may be longer in smaller stable cases, but one schedule does not apply to every segment. The need for serial examinations should be explained clearly so that an asymptomatic patient does not regard absence of symptoms as a reason to stop follow-up.

The decision on preventive repair integrates diameter, growth rate, attributable symptoms, morphology and wall susceptibility. Thresholds differ by site, by sex in some regions, by genetic syndrome and by the planned procedure. No single number therefore applies to every aneurysm. Infection, pseudoaneurysm or signs of contained rupture may make waiting for an ordinary size threshold irrelevant. Conversely, marked frailty or limited life expectancy may reduce the benefit of a technically possible intervention.

Open surgery replaces the diseased segment with a vascular graft and, in proximal regions, may require valve repair or replacement and coronary reimplantation. It offers durable solutions but entails an operative burden that varies enormously by site and patient. Cerebral, spinal cord, renal and visceral protection becomes increasingly important during extensive operations. Risk assessment must consider the actual procedure proposed and center experience, avoiding attribution of the outcomes of limited elective ascending replacement to thoracoabdominal reconstruction.

Endovascular treatment excludes the sac from the blood flow with a stent graft anchored in suitable segments. It is widely used for favorable anatomy in the abdominal and descending thoracic aorta; in more complex regions it may require dedicated devices and branch reconstructions. Lower initial invasiveness does not eliminate anatomical requirements or the need for subsequent monitoring. In hereditary connective tissue disorders, native aortic quality may limit anchoring durability, so selection must also consider how the wall is likely to change over many years.

Daily activities are adapted to risk without automatically imposing inactivity. Moderate aerobic exercise with controlled blood pressure and appropriate clinical assessment can support cardiovascular health and quality of life; maximal efforts, Valsalva maneuvers and blood pressure surges require greater caution. Pregnancy requires specific planning in predisposing aortopathies, including medication review and maternal surveillance. Counseling should address both reasonably feasible activities and symptoms that warrant emergency assistance, rather than relying on generic restrictions that are the same for everyone.

Prognosis, complications and continuity of care

The prognosis of a stable aneurysm depends on the probability of expansion and an acute event, as well as overall cardiovascular risk. Cohorts of ascending aneurysms show increasing risk with size, with absolute estimates varying according to population, surgical selection and events included. A percentage drawn from a referral center cannot be transferred without adjustment to a patient followed through a screening program. Individual risk requires joint interpretation of population data and personal history.

The most feared complication is aortic rupture, causing internal hemorrhage and possible collapse. In the proximal aorta, bleeding may enter the pericardium and cause tamponade; in thoracic and abdominal regions it may enter the pleural cavity, mediastinum or retroperitoneum. Dissection may impair branch flow, causing cerebral, coronary, visceral, renal or peripheral ischemia. Such events are not always preceded by documented diameter growth and may present mainly with an organ-specific symptom rather than pain considered typical.

Other complications include progressive aortic regurgitation, compression, embolism and, less commonly, abnormal communications with adjacent structures. Repair adds specific risks: bleeding, infection, organ ischemia and anastomotic problems with surgery; persistent flow within the sac, migration or device changes with endovascular treatment. An endoleak does not always have the same clinical significance: source, transmitted pressure and sac-size trend guide management. Initial technical success alone does not justify discontinuing follow-up.

Post-repair surveillance considers both the graft and the residual aorta. Diffuse or hereditary disease may progress in segments that were normal or only mildly dilated at surgery, while an excluded sac may change over time. Follow-up therefore includes appropriate imaging, risk-factor control, functional assessment and recognition of new symptoms. Continuity between cardiology, surgery and community-based medicine helps turn a potentially catastrophic diagnosis into a monitored condition in which preventing emergencies remains the central objective.

Bibliography
  1. Isselbacher EM et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;80(24):e223–e393.
  2. Mazzolai L et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45(36):3538–3700.
  3. Wanhainen A et al. Editor's Choice – European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. European Journal of Vascular and Endovascular Surgery. 2024;67(2):192–331.
  4. Bossone E et al. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nature Reviews Cardiology. 2021;18(5):331–348.
  5. Humphrey JD et al. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circulation Research. 2015;116(8):1448–1461.
  6. Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nature Reviews Cardiology. 2019;16(4):225–242.
  7. Renard M et al. Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. Journal of the American College of Cardiology. 2018;72(6):605–615.
  8. Rodríguez-Palomares JF et al. Mechanisms of Aortic Dilation in Patients With Bicuspid Aortic Valve: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2023;82(5):448–464.
  9. Asch FM et al. The Need for Standardized Methods for Measuring the Aorta: Multimodality Core Lab Experience From the GenTAC Registry. JACC: Cardiovascular Imaging. 2016;9(3):219–226.
  10. Evangelista A et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. European Heart Journal – Cardiovascular Imaging. 2023;24(5):e65–e85.
  11. Owens DK et al. Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(22):2211–2218.
  12. Pitcher A et al. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. The Lancet. 2022;400(10355):822–831.
  13. Baxter BT et al. Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA. 2020;323(20):2029–2038.
  14. Solomon MD et al. Association of Thoracic Aortic Aneurysm Size With Long-term Patient Outcomes: The KP-TAA Study. JAMA Cardiology. 2022;7(11):1160–1169.
  15. Wu J et al. Fate of the unoperated ascending thoracic aortic aneurysm: three-decade experience from the Aortic Institute at Yale University. European Heart Journal. 2023;44(43):4579–4588.
  16. Wilson WR et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016;134(20):e412–e460.
  17. Li J et al. Safety of exercise for adults with thoracic aortic aneurysms and dissections. Frontiers in Sports and Active Living. 2022;4:888534.
  18. De Backer J et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Heart Journal. 2025;46(43):4462–4568.
  19. Gupta Y et al. CIRSE Standards of Practice on the Endovascular Management of Descending Thoracic Aortic Disease. Cardiovascular and Interventional Radiology. 2026;49:1645–1656.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.